BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 35040086)

  • 21. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae.
    Wu J; Tang L; Ma Y; Li Y; Zhang D; Li Q; Mei H; Hu Y
    mBio; 2021 Oct; 12(5):e0159921. PubMed ID: 34488453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients.
    Rovito R; Bono V; Augello M; Tincati C; Mainoldi F; Beaudoin-Bussières G; Tauzin A; Bianchi S; Hadla M; Yellenki V; d'Arminio Monforte A; Casola S; Borghi E; Finzi A; Marchetti G
    Sci Rep; 2022 Nov; 12(1):19658. PubMed ID: 36385627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
    Smail SW; Babaei E; Amin K; Abdulahad WH
    Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 convalescent plasma composition and immunological effects in severe patients.
    Acosta-Ampudia Y; Monsalve DM; Rojas M; Rodríguez Y; Gallo JE; Salazar-Uribe JC; Santander MJ; Cala MP; Zapata W; Zapata MI; Manrique R; Pardo-Oviedo JM; Camacho B; Ramírez-Santana C; Anaya JM;
    J Autoimmun; 2021 Mar; 118():102598. PubMed ID: 33524876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.
    Idiz UO; Yurttas TT; Degirmencioglu S; Orhan B; Erdogan E; Sevik H; Sevinc MM
    J Med Virol; 2022 Oct; 94(10):4744-4753. PubMed ID: 35667877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In search of immune cellular sources of abnormal cytokines in the blood in autism spectrum disorder: A systematic review of case-control studies.
    Nour-Eldine W; Ltaief SM; Abdul Manaph NP; Al-Shammari AR
    Front Immunol; 2022; 13():950275. PubMed ID: 36268027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.
    Romano A; Parrinello NL; Barchitta M; Manuele R; Puglisi F; Maugeri A; Barbato A; Triolo AM; Giallongo C; Tibullo D; La Ferla L; Botta C; Siragusa S; Iacobello C; Montineri A; Volti GL; Agodi A; Palumbo GA; Di Raimondo F
    Sci Rep; 2022 May; 12(1):7237. PubMed ID: 35508575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2-reactive IFN-γ-producing CD4
    Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
    Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central Inflammatory Cytokines in Tuberculous Meningitis: A Systematic Review and Meta-analysis.
    Saghazadeh A; Rezaei N
    J Interferon Cytokine Res; 2022 Mar; 42(3):95-107. PubMed ID: 35298290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
    Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
    Majeed AY; Zulkafli NES; Ad'hiah AH
    Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
    Brito-Melo GE; Peruhype-Magalhães V; Teixeira-Carvalho A; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; ; Martins-Filho OA
    Clin Exp Immunol; 2007 Jan; 147(1):35-44. PubMed ID: 17177961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
    Chen X; Huang J; Huang Y; Chen J; Huang Y; Jiang X; Shi Y
    Hum Immunol; 2020 Dec; 81(12):702-708. PubMed ID: 32950268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study.
    Kang Y; Lu S; Zhong R; You J; Chen J; Li L; Huang R; Xie Y; Chen F; Chen J; Chen L
    Heliyon; 2024 Jan; 10(1):e23583. PubMed ID: 38173531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.